We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFUS icon
76
Littelfuse
LFUS
$9.8B
$51.7M 0.41%
226,749
ESGR
77
DELISTED
Enstar Group
ESGR
$50.7M 0.4%
244,572
SUM
78
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$50.4M 0.4%
+1,950,797
New +$54.4M
PEN icon
79
Penumbra
PEN
$12.6B
$49.9M 0.39%
361,292
NKTR icon
80
Nektar Therapeutics
NKTR
$2.35B
$49.7M 0.39%
67,820
+19,792
+41% +$22.8M
UEIC icon
81
Universal Electronics
UEIC
$58.2M
$49.7M 0.39%
1,502,697
HRTX icon
82
Heron Therapeutics
HRTX
$91.8M
$49.5M 0.39%
1,274,695
ODFL icon
83
Old Dominion Freight Line
ODFL
$47.6B
$48.9M 0.39%
985,188
+255,468
+35% +$12.7M
MCHP icon
84
Microchip Technology
MCHP
$41.8B
$48.7M 0.38%
1,071,412
+140,668
+15% +$6.52M
XYZ
85
Block Inc
XYZ
$49.3B
$48.3M 0.38%
784,238
-69,448
-8% -$3.82M
VOYA icon
86
Voya Financial
VOYA
$9.02B
$48.2M 0.38%
1,025,400
+154,150
+18% +$7.98M
ATRA icon
87
Atara Biotherapeutics
ATRA
$68.6M
$47.3M 0.37%
51,458
ATO icon
88
Atmos Energy
ATO
$30.4B
$47.2M 0.37%
523,549
+20,425
+4% +$1.77M
FND icon
89
Floor & Decor
FND
$6.19B
$47M 0.37%
953,632
+465,103
+95% +$23.9M
LGND icon
90
Ligand Pharmaceuticals
LGND
$5.96B
$46.5M 0.37%
359,748
LHX icon
91
L3Harris
LHX
$56.8B
$45.9M 0.36%
317,758
-49,096
-13% -$7.6M
BC icon
92
Brunswick
BC
$5.37B
$45.8M 0.36%
710,623
+86,896
+14% +$5.42M
ADSK icon
93
Autodesk
ADSK
$50.7B
$45.4M 0.36%
346,283
+42,472
+14% +$5.63M
RBA icon
94
RB Global
RBA
$21.8B
$45.2M 0.36%
1,324,455
+225,000
+20% +$7.59M
NVDA icon
95
NVIDIA
NVDA
$4.78T
$44.4M 0.35%
9,270,280
+2,959,480
+47% +$18M
KYNB
96
Kyntra Bio
KYNB
$29M
$44.3M 0.35%
28,333
+4,294
+18% +$5.6M
HUN icon
97
Huntsman Corp
HUN
$2.03B
$44.1M 0.35%
1,511,186
+552,612
+58% +$17.1M
SRG
98
Seritage Growth Properties
SRG
$130M
$43.8M 0.34%
1,032,564
MCO icon
99
Moody's
MCO
$84.4B
$43.6M 0.34%
255,890
+28,096
+12% +$4.76M
STZ icon
100
Constellation Brands
STZ
$22.5B
$43.2M 0.34%
197,285
+16,739
+9% +$3.78M

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.